Meeting
2017 ASCO Annual Meeting
Tumor mutational burden (TMB) and co-existing actionable mutations in biliary tract cancers (BTC).
Authors
Apurva Jain
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Apurva Jain , Rachna T. Shroff , Mingxin Zuo , Jacqueline Weatherly , Randi Isaacs , Siraj Mahamed Ali , Tanios S. Bekaii-Saab , Milind M. Javle , Funda Meric-Bernstam
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 4086)
DOI
10.1200/JCO.2017.35.15_suppl.4086
Abstract #
4086
Poster Bd #
78
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Immunotherapy (IO) versus targeted therapy triage in endometrial adenocarcinoma (EA) by concurrent assessment of tumor mutation burden (TMB), microsatellite instability (MSI) status, and targetable genomic alterations (GA).
First Author: Alessandro Santin
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff
Poster
2023 ASCO Annual Meeting
Blood-based assessment of patients with mismatch repair-deficient tumors enrolled in NCI-MATCH Arm Z1D (nivolumab).
First Author: Chris Alan Karlovich
Poster
2022 ASCO Annual Meeting
Impact of RAS mutations on immunologic characteristics of the tumor microenvironment (TME) in patients with microsatellite instability-high (MSI-H) or mismatch-repair–deficient (dMMR) colorectal cancer (CRC).
First Author: Mohamed E. Salem